BGI Genomics Co., Ltd. (SHE:300676)
China · Delayed Price · Currency is CNY 33.60
-1.32 (-3.78%)
Jun 8, 2026, 3:04 PM CST
BGI Genomics Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 12,897 | 17,411 | 16,005 | 19,676 | 21,188 | 35,990 | |
Market Cap Growth | -33.04% | 8.78% | -18.66% | -7.14% | -41.13% | -29.32% |
Enterprise Value | 10,248 | 14,511 | 11,837 | 14,568 | 14,557 | 28,800 |
Last Close Price | 33.60 | 45.36 | 41.97 | 47.86 | 50.67 | 85.65 |
PE Ratio | - | - | - | 211.80 | 26.39 | 24.63 |
Forward PE | - | 25.09 | 25.09 | 25.09 | 25.09 | 35.26 |
PS Ratio | 3.36 | 4.70 | 4.14 | 4.52 | 3.00 | 5.32 |
PB Ratio | 1.51 | 2.02 | 1.73 | 1.97 | 2.07 | 3.81 |
P/TBV Ratio | 1.62 | 2.16 | 1.83 | 2.10 | 2.20 | 3.99 |
P/FCF Ratio | - | - | - | - | - | 17.20 |
P/OCF Ratio | 84.56 | - | 167.21 | 48.14 | 161.89 | 14.54 |
EV/Sales Ratio | 2.67 | 3.92 | 3.06 | 3.35 | 2.06 | 4.26 |
EV/EBITDA Ratio | - | - | - | 30.18 | 11.53 | 14.70 |
EV/EBIT Ratio | - | - | - | 128.98 | 16.08 | 17.14 |
EV/FCF Ratio | -28.78 | - | - | - | - | 13.76 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.09 |
Debt / EBITDA Ratio | - | - | - | 0.66 | 0.15 | 0.41 |
Debt / FCF Ratio | - | - | - | - | - | 0.41 |
Net Debt / Equity Ratio | -0.32 | -0.36 | -0.41 | -0.51 | -0.61 | -0.83 |
Net Debt / EBITDA Ratio | 51.64 | 22.96 | 12.51 | -10.65 | -4.91 | -3.98 |
Net Debt / FCF Ratio | 7.75 | 5.52 | 8.85 | 6.22 | 5.46 | -3.73 |
Asset Turnover | 0.32 | 0.31 | 0.30 | 0.31 | 0.49 | 0.53 |
Inventory Turnover | 4.90 | 4.50 | 3.93 | 3.34 | 4.42 | 3.02 |
Quick Ratio | 2.31 | 2.17 | 2.13 | 2.13 | 2.23 | 2.94 |
Current Ratio | 2.60 | 2.42 | 2.42 | 2.41 | 2.47 | 3.26 |
Return on Equity (ROE) | -6.67% | -7.13% | -9.46% | 0.93% | 8.23% | 19.11% |
Return on Assets (ROA) | -2.71% | -3.06% | -3.52% | 0.50% | 3.95% | 8.25% |
Return on Invested Capital (ROIC) | -9.22% | -10.91% | -14.31% | 2.06% | 25.71% | 79.94% |
Return on Capital Employed (ROCE) | -5.70% | -6.50% | -7.60% | 1.10% | 8.70% | 15.50% |
Earnings Yield | -4.45% | -3.54% | -5.64% | 0.47% | 3.79% | 4.06% |
FCF Yield | -2.76% | -3.27% | -2.71% | -4.21% | -5.36% | 5.81% |
Dividend Yield | - | - | - | 0.21% | 1.97% | 0.41% |
Payout Ratio | - | - | - | 448.58% | 20.82% | 12.16% |
Buyback Yield / Dilution | -0.98% | -0.96% | -0.01% | -0.48% | 0.32% | -3.11% |
Total Shareholder Return | -0.98% | -0.96% | -0.01% | -0.27% | 2.29% | -2.70% |